Добавил:
kiopkiopkiop18@yandex.ru Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
5 курс / Пульмонология и фтизиатрия / Interventions_in_Pulmonary_Medicine_Díaz_Jimenez.pdf
Скачиваний:
2
Добавлен:
24.03.2024
Размер:
58.79 Mб
Скачать

20  Bronchoscopy Role in the Evaluation of Peripheral Pulmonary Lesions: An Overview

359

 

 

ROSE. Diagnostic yield was higher in the ROSE group, both for lesions >20 mm (88.0% vs. 77.6%) and for PPLs ≤20 mm (88.0% vs. 77.6%). Furthermore, in the non-ROSE group, the number of biopsies, the hemorrhage rate and the operation times were all higher than that of the ROSE group [58].

In the meta-analysis by Mondoni et al. [54], evaluating the yield of fuoroscopic-guided TBNA on 18 studies, a signi cant improvement of diagnostic yield is reported when ROSE was performed. Furthermore, the authors underline the possible role of a positive and adequate material on ROSE in stopping additional sampling, thus potentially avoiding the use of useless forceps biopsy and reducing risk.

The meta-analysis by Sainz Zuniga et al. [35], evaluating 51 studies performed with rEBUS, reports that the use of ROSE was associated with a higher sensitivity, even if only a small number of studies (n = 4) used ROSE in this review, leading the author to conclude that this nding requires further consideration.

From the above mentioned data, there is some evidence that ROSE may be useful in the transbronchial approach to PPLs, while it would be desirable to have more large randomized trials to de nitely assess the real advantage of rapid on-­ site evaluation with the different guidance systems and with different sampling techniques employed.

Conclusions

Even though many years have passed and great progress has been made since the rst papers on the possibility of bronchoscopy to diagnose pulmonary peripheral lesions, the transbronchial approach to PPLs still remains a challenging task for bronchoscopists.

The aim is to diagnose smaller and smaller lesions and to improve the diagnostic yield, making the bronchoscopic sampling equivalent in terms of sensitivity to the percutaneous biopsy, which is burdened by a higher risk of complications. The major obstacle that limits the diagnos-

tic yield of the transbronchial sampling, whatever guidance system is used, is represented by the location of some PPLs that have no relationship with the airways.

In this chapter, we have provided an overview of all the techniques at this moment available.

The accuracy of all the guidance systems mentioned could be further increased with the use of ultrathin bronchoscopes and of robotic bronchoscopy, which we have not considered, since there are speci c dedicated chapters in this book.

Although, from comparison of different papers and from meta-analyses it seems that the new guidance systems may provide better results, especially for small lesions, there are no large randomized trials the compare the various technologies. The heterogeneity of results makes dif cult the comparison between different studies, since several variables play a role in determining the diagnostic yield of the transbronchial approach to PPLs (size and nature of the lesions, their location, their relationships with the bronchial tree, the type and the number of sampling instruments, operator experience, multiple guidance system used at the same time, time employed, availability of ROSE).

Furthermore, the problem of costs should also be considered. The new technologies are burdened by high costs, for both the equipment and the disposable material, and cannot be available everywhere. The identi cation of Centers of excellence, where high technologies must be concentrated, should be part of health policy programs of each Country.

Due to these reasons, the use of one or more guidance systems and of one or more sampling instruments is still linked to the operator’s experience and/or to the local availability of facilities and resources.

The interventional pulmonologist community would deserve more scienti c evidence and more well conducted randomized trials, that could allow a standardization of the transbronchial approach to PPLs and to de ne the best strategy to be followed.

Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/

360

S. Gasparini and L. Zuccatosta

 

 

References

1.\Gasparini S. Diagnostic management of solitary pulmonary nodule. Eur Respir Mon. 2010;48:90–108. https://doi.org/10.1183/1025448x.00990709.

2.\Torrington KG, Kern JD. The utility of beroptic bronchoscopy in the evaluation of the solitary pulmonary nodule. Chest. 1993;104:1021–4. https://doi. org/10.1378/chest.104.4.1021.

3.\Arsitizabal JF, Young R, Nath H. Can chest CT decrease the use of preoperative bronchoscopy in the evaluation of suspected bronchogenic carcinoma? Chest. 1998;113:1244–9. https://doi.org/10.1378/ chest.113.5.1244.

4.\Chhajed PN, Bernasconi M, Gambazzi F, et al. Combining bronchoscopy and positron emission tomography for the diagnosis of the small pulmonary nodule ≤ 3 cm. Chest. 2005;128:3558–64. https://doi. org/10.1378/chest.128.5.3558.

5.\Schwarz C, Schonfeld N, Bittner RC, et al. Value of fexible bronchoscopy in the preop-

erative work-up of

solitary pulmonary nod-

ules. Eur Respir J.

2013;41:177–82. https://doi.

org/10.1183/09031936.00018612.

6.\Tsuboi E. Studies on an early diagnosis of lung cancer-­especially cytological diagnosis of bronchial cells obtained by a direct scrape-off method. Nipp Act Radiol. 1959;19:133–51.

7.\Wang KP, Haponik EF, Britt EJ, et al. Transbronchial needle aspiration of peripheral pulmonary nodules. Chest. 1984;86:819–23. https://doi.org/10.1378/ chest.86.6.819.

8.\Asano F, MatsunoY, MatsushitaT, et al.Transbronchial diagnosis of a pulmonary peripheral small lesion using an ultrathin bronchoscope with virtual bronchoscopic navigation. J Bronchol. 2002;9:108–11.

9.\Herth FJF, Ernst A, Becker H. Endobronchial ultrasound-­guided transbronchial lung biopsy in solitary pulmonary nodules and peripheral lesions. Eur Respir J. 2002;20:972–4. https://doi.org/10.1183/090 31936.02.00032001.

10.\Kurimoto N, Miyazawa T, Okimasa S, et al. Endobronchial ultrasonography using a guide sheath increases the ability to diagnose peripheral pulmonary lesions endoscopically. Chest. 2004;126:959–65. https://doi.org/10.1378/chest.126.3.959.

11.\Becker HD, Herth FJ, Ernst A. Bronchoscopic biopsy of peripheral lung lesions under electromagnetic guidance. J Bronchol. 2005;12:9–13. https://doi. org/10.1097/01.laboratory.0000147032.67754.22.

12.\Casal RF, Sarkiss M, Jones AK, et al. Cone beam computed tomography-guided thin/ultrathin bronchoscopy for diagnosis of peripheral lung nodules: a prospective pilot study. J Thorac Dis. 2018;10(12):6950–9. https://doi.org/10.21037/jtd.2018.11.21.

13.\Sobieszczyk MJ, Yuan Z, Li W, et al. Biopsy of peripheral lung nodules utilizing cone beam computer tomography with and without trans bronchial access tool: a retrospective analysis. J Thorac

Dis. 2018;10:5953–9. https://doi.org/10.21037/ jtd.2018.09.16.

14.\Pertzov B, Gershman E, Kassirer M, Heching M, Rosengarten D, Kramer M. Use of LUNGVISION navigational system to improve diagnostic yield of peripheral lung nodule biopsy. Chest. 2019;156:A385.

15.\Pritchett MA. Prospective analysis of a novel endobronchial augmented fuoroscopic navigation system for diagnosis of peripheral pulmonary lesions. J Bronchology Interv Pulmonol. 2021;28:107–15. https://doi.org/10.1097/LBR.0000000000000700.

16.\Eberhardt R, Anantham D, Ernst A, et al. Multimodality bronchoscopic diagnosis of peripheral lung lesions: a randomized controlled trial. Am J Respir Crit Care Med. 2007;176:36–41. https://doi. org/10.1164/rccm.200612-1866OC.

17.\Herth FJ, Eberhardt R, Sternman D, et al. Bronchoscopic transparenchymal nodule access (BTPNA): rst in human trial of a novel procedure for sampling solitary pulmonary nodules. Thorax. 2015;70:326–32. https://doi.org/10.1136/ thoraxjnl-2014-206211.

18.\Prakash UB. The use of the pediatric beroptic bronchoscope in adults.Am Rev Respir Dis. 1985;132:715– 7. https://doi.org/10.1164/arrd.1985.132.3.715.

19.\Oki M, Saka H, Kitagawa C, et al. Novel thin bronchoscope with a 1.7-mm working channel for peripheral pulmonary lesions. Eur Respir J. 2008;32:465–71.

https://doi.org/10.1183/09031936.00169107.

 

20.\Gasparini

S.

Conventional

biopsy

tech-

niques.

In: Ernst A,

Herth

F,

editors.

Principles

and

practice

of

interventional

pulmonology. New York: Springer; 2013. https:// doi.org/10.1007/978-1-4614-4292-9_15.

21.\Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer. diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:142–65. https://doi. org/10.1378/chest.12-2353.

22.\Dasgupta A, Mehta AC. Transbronchial needle aspiration: an underused diagnostic technique. Clin Chest Med. 1999;20:39–51. https://doi.org/10.1016/ S0272-5231(05)70125-8.

23.\Baaklini WA, Reinoso MA, Gorin AB, et al. Diagnostic yield of beroptic bronchoscopy in evaluating solitary pulmonary nodules. Chest. 2000;117:1049–54. https://doi.org/10.1378/ chest.117.4.1049.

24.\Radke JR, Conway WA, Eyler WR, et al. Diagnostic accuracy in peripheral lung lesions: factors predicting success with fexible beroptic bronchoscopy. Chest. 1979;76:176–9. https://doi.org/10.1378/ chest.76.2.176.

25.\Naidich DP, Sussman R, Kutcher WL, et al. Solitary pulmonary nodules: CT-bronchoscopic correlation. Chest. 1988;93:595–8. https://doi.org/10.1378/ chest.93.3.595.

20  Bronchoscopy Role in the Evaluation of Peripheral Pulmonary Lesions: An Overview

361

 

 

26.\Ali MS, Sethi J, Taneja A, et al. Computed tomography bronchus sign and the diagnostic yield of guided bronchoscopy for peripheral pulmonary lesions. A systematic review and meta-analysis. Ann Am Thorac Soc. 2018;15:978–87. https://doi.org/10.1513/ AnnalsATS.201711-856OC.

27.\Mori K, Yanase N, Kaneko M, et al. Diagnosis of peripheral lung cancer in cases of tumors 2 cm or less in size. Chest. 1989;95:304–8. https://doi. org/10.1378/chest.95.2.304.

28.\Gasparini S, Ferretti M, Bichi Secchi E, et al. Integration of transbronchial and percutaneous approach in the diagnosis of peripheral pulmonary nodules or masses: experience with 1,027 consecutive cases. Chest. 1995;108:131–7. https://doi. org/10.1378/chest.108.1.131.

29.\Ali EAA, Takizawa H, Kawakita N, et al. Transbronchial biopsy using an ultrathin bronchoscope guided by cone-beam computed tomography and virtual bronchoscopic navigation in the diagnosis of pulmonary nodules. Respiration. 2019;98:321–8. https://doi.org/10.1159/000500228.

30.\Bilaceroglu S, Kumcuoglu Z, Alper H, et al. CT bronchus sign-guided bronchoscopic multiple diagnostic procedures in carcinomatous solitary pulmonary nodules and masses. Respiration. 1998;65:49–55. https:// doi.org/10.1159/000029237.

31.\Reichenberger F, Weber J, Tamm M, et al. The value of transbronchial needle aspiration in the diagnosis of peripheral pulmonary lesions. Chest. 1999;116:704– 8. https://doi.org/10.1378/chest.116.3.704.

32.\Steinfort DP, Khor YH, Manser RL, Irving LB. Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and metaanalysis. Eur Respir J. 2011;37(4):902–10. https:// doi.org/10.1183/09031936.00075310.

33.\Ali MS, Trik W, Mba I, et al. Radial endobronchial ultrasound for the diagnosis of peripheral pulmonary lesions: a systematic review and meta-­ analysis. Respirology. 2017;22:443–53. https://doi. org/10.1111/resp.12980.

34.\Zhan P, Zhu QQ, Miu YY, et al. Comparison between endobronchial ultrasound-guided transbronchial biopsy and CT-guided transthoracic lung biopsy for the diagnosis of peripheral lung cancer: a systematic review and meta-analysis. Transl Lung Cancer Res. 2017;6:23–34. https://doi.org/10.21037/ tlcr.2017.01.01.

35.\Sainz Zuniga PV, Vakil E, Molina S, et al. Sensitivity of radial endobronchial ultrasound-guided bronchoscopy for lung cancer in patients with peripheral pulmonary lesions. An updated meta-analysis. Chest. 2020;157:994–1011. https://doi.org/10.1016/j. chest.2019.10.042.

36.\Gasparini S, Mei F, Bonifazi M, et al. Bronchoscopic diagnosis of peripheral pulmonary lesions. Curr Opin Pulm Med. 2022;28:31–6. https://doi.org/10.1097/ MCP.0000000000000842.

37.\Tanner NT, Yarmus L, Chen A, et al. Standard bronchoscopy with fuoroscopy vs thin bronchoscopy

and radial endobronchial ultrasound for biopsy of pulmonary lesions: a multicenter, prospective, randomized trial. Chest. 2018;154:1035–43. https://doi. org/10.1016/j.chest.2018.08.1026.

38.\Triller N, Dimitrijevic J, Rozman A. A comparative study on endobrochial ultrasound-guided and fuoroscopic-­guided transbronchial lung biopsy of peripheral pulmonary lesions. Respir Med. 2011;105:S74–7. https://doi.org/10.1016/ S0954-6111(11)70015-4.

39.\Nakajima T, Yasufuku K, Fujiwara T, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of intrapulmonary lesions. J Thorac Oncol. 2008;3:985–8. https://doi. org/10.1097/JTO.0b013e31818396b9.

40.\Ishida T, Asano F, Yamazaki K, et al. Virtual bronchoscopic navigation combined with endobronchial ultrasound to diagnose small peripheral pulmonary lesions: a randomised trial. Thorax. 2011;66:1072–7. https://doi.org/10.1136/thx.2010.145490.

41.\Asano F, Shinigawa N, Ishida T, et al. Virtual bronchoscopic navigation combined with ultrathin bronchoscopy. A randomized clinical trial. Am J Respir Crit Care Med. 2013;188:327–33. https://doi.org/10.1164/ rccm.201211-2104OC.

42.\Asano F, Eberhardt R, Herth FJF. Virtual bronchoscopy navigation for peripheral pulmonary lesions. Respiration. 2014;88:430–40. https://doi. org/10.1159/000367900.

43.\Gex G, Pralong JA, Combescure C, et al. Diagnostic yield and safety of electromagnetic navigation bronchoscopy for lung nodules: a systematic review and meta-analysis. Respiration. 2014;87:165–76. https:// doi.org/10.1159/000355710.

44.\Zhang W, Chen S, Dong X, et al. Meta-analysis of the diagnostic yield and safety of electromagnetic navigation bronchoscopy for lung nodules. J Thorac Dis. 2015;7:799–809. https://doi.org/10.3988/j. ssn.2072-1439.2015.04.46.

45.\Folch EE, Labarca G, Ospina-Delgado D. Sensitivity and safety of electromagnetic navigation bronchoscopy for lung cancer diagnosis. Systematic review and meta-analysis. Chest. 2020;158:1753–69. https:// doi.org/10.1016/j.chest.2020.05.534.

46.\Qian K, Krimsky WS, Sarkar SA, et al. Ef ciency of electromagnetic navigation bronchoscopy and virtual bronchoscopic navigation. Ann Thorac Surg. 2020;109:1731–40. https://doi.org/10.1016/j. athoracsur.2020.01.019.

47.\Ost DE, Ernst A, Lei X, et al. Diagnostic yield and complications of bronchoscopy for peripheral lung lesions. Results of the AQuIRE registry. Am J Respir Crit Care Med. 2016;193:68–77. https://doi. org/10.1164/rccm.201507-1332OC.

48.\Folch EE, Pritchett MA, Nead MA, et al. Electromagnetic navigation bronchoscopy for peripheral pulmonary lesions: one-year results of the prospective, multicenter NAVIGATE study. J Thorac Oncol. 2019;14:445–8. https://doi.org/10.1016/j. jtho.2018.11.013.

Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/

362

S. Gasparini and L. Zuccatosta

 

 

49.\Aboudara M, Roller L, Rickman O, et al. Improved diagnostic yield for lung nodules with digital tomosynthesis-­corrected navigational bronchoscopy: initial experience with a novel adjunct. Respirology. 2020;25:206–13. https://doi. org/10.1111/resp.13609.

50.\Harzheim D, Sterman D, Shah PL, et al. Bronchoscopic transparenchymal nodule access: feasibility and safety in an endoscopic unit. Respiration. 2016;91:302–6. https://doi.org/10.1159/000445032.

51.\Pritchett MA, Schampaert S, de Groot JAH, et al. Cone-beam CT with augmented fuoroscopy combined with electromagnetic navigation bronchoscopy for biopsy of pulmonary nodules. J Bronchol Interv Pulmonol. 2018;25:274–82. https://doi.org/10.1097/ LBR.0000000000000536.

52.\De Gracia J, Bravo C, Miravitlles M, et al. Diagnostic value of bronchoalveolar lavage in peripheral lung cancer. Am Rev Respir Dis. 1993;147:649–52. https:// doi.org/10.1164/ajrccm/147.3.649.

53.\Trisolini R, Cancellieri A, Tinelli C, et al. Performance characteristics and predictors of yield from transbronchial needle aspiration in the diagnosis of peripheral pulmonary lesions. Respirology. 2011;16:1144–9. https://doi.org/10.1111/j.1440-1843-2011-02026x.

54.\Mondoni M, Sotgiu G, Bonifazi M, et al. Transbronchial needle aspiration in peripheral pul-

monary lesions: a systematic review and meta analysis. Eur Respir J. 2016;48:196–204. https://doi. org/10.1183/13993003.00051-2016.

55.\Tremblay A, Myers R, Beaudoin EL, et al. Initial clinical experience with a fexible peripheral 21-G needle device. J Bronchol Interv Pulmonol. 2018;25:346–8. https://doi.org/10.1097/ LBR.0000000000000505.

56.\Gildea TR, Folch EE, Khandhar SJ, et al. The impact of biopsy tool choice and rapid on-site evaluation on diagnostic accuracy for malignant lesions in the prospective: multicenter NAVIGATE study. J Bronchol Interv Pulmonol. 2021;28:174–83. https://doi. org/10.1097/LBR.0000000000000740.

57.\Sryma PB, Mittal S, Madan NK, et al. Ef cacy of radial endobronchial ultrasound (R-EBUS) guided transbronchial cryobiopsy for peripheral pulmonary lesions (PPL’s): a systematic review and meta-­ analysis. Respirology. 2021. https://doi.org/10.1016/j. pulmoe.2020.12.006.

58.\Chunhua X, Wang W, Yuan Q, et al. Rapid on-site evaluation during radial endobronchial ultrasound– guided transbronchial lung biopsy for the diagnosis of peripheral pulmonary lesions. Technol Cancer Res Treat. 2020;19:1533033820947482. https://doi. org/10.1177/1533033820947482.

Early Lung Cancer: Methods

21

for Detection

Takahiro Nakajima and Kazuhiro Yasufuku

Introduction and De nition of the Procedure

Lung cancer is the leading cause of cancer mortality worldwide [1]. Despite evolving knowledge of lung cancer molecular genetics and improved lung cancer detection technology, the overall lung cancer survival is still quite poor (18–21%-5-year survival) [1]. National Lung cancer Screening Trial showed a dramatic, 20% relative decrease in lung cancer mortality with low dose CT chest screening in high-risk groups [2], proving the concept that early lung cancer detection which allows prompt surgical intervention, offers survival bene t. However, screening CT thorax detects smaller peripheral lung lesions, but is insensitive for detection of microscopic tumors arising from the central airways [3]. Microscopic tumors arising in the central airways require other techniques for early detection [4].

Squamous cell carcinomas, accounting for approximately 25–30% of all lung cancers, arise in central airways. Pathobiologically, progression

T. Nakajima

Department of General Thoracic Surgery, Dokkyo Medical University, Mibu, Tochigi, Japan

e-mail: takahiro_nakajima@med.miyazaki-u.ac.jp

K. Yasufuku (*)

Division of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada

e-mail: kazuhiro.yasufuku@uhn.ca

from normal bronchial epithelium to squamous metaplasia followed by dysplasia, carcinoma in situ (CIS), and nally invasive carcinoma has been well described [5, 6]. Studies have shown that patients with preinvasive bronchial lesions progress to develop CIS/invasive carcinoma over the median time of 24 months (range: 6–54 months) [7]. Approximately 11% of patients with moderate dysplasia and 19% to as high as 50% with severe dysplasia develop invasive carcinoma [8, 9]. The existence of COPD or heavy smoking history are at high risk of developing lung cancer [7]. Therefore, prompt detection through screening of high-risk patients (heavy smokers especially) could potentially offer early diagnosis of early preinvasive or early invasive lesions and allow for prompt therapeutic intervention and improved survival. However, conventional airway imaging modality, white light bronchoscopy (WLB) has been shown to be relatively insensitive in inspection of bronchial mucosa with only 30% sensitivity to detect early-stage carcinoma in the central airways [10].

New bronchoscopic modalities with higher spatial resolution are able to take advantage of intrinsic properties of healthy and abnormal tissues to change appearance when illuminated with different wavelengths of light, have been developed to serve the purpose of more advanced central airway imaging for the purpose of abnormal airway diagnosis [11]. Currently available in clinical practice modalities for detecting bron-

© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023

363

J. P. Díaz-Jiménez, A. N. Rodríguez (eds.), Interventions in Pulmonary Medicine, https://doi.org/10.1007/978-3-031-22610-6_21

Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/